Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
27 March 2026Developing public health risk messages about antibiotic resistance using metaphors: an international co-design and e-Delphi consensus study
This study presents an international co-design and e-Delphi consensus process to develop more effective public health messages about antimicrobial resistance (AMR), focusing specifically on the use of metaphors. The researchers engaged experts and stakeholders to identify which types of metaphors best communicate AMR risks and motivate behavioural change. They found that commonly used “war” or […]
Read more... -
23 March 2026The role of breastfeeding in modulating antimicrobial resistance in neonates: a systematic review
A systematic review (2015–2025) shows that breastfeeding plays a complex but important role in antimicrobial resistance (AMR) in newborns. Breast milk actively shapes the infant gut microbiome and can both introduce antimicrobial resistance genes (ARGs) and help limit their spread by promoting beneficial bacteria and suppressing harmful, drug-resistant strains. The overall impact depends strongly on […]
Read more... -
20 March 2026Point-of-care testing strategy versus usual care to safely reduce antibiotic prescribing for acute respiratory tract infections in primary care (PRUDENCE): a pragmatic, randomised controlled trial in 13 countries
The PRUDENCE trial evaluated whether point-of-care (POC) testing (including CRP, strep A, and influenza tests) could reduce antibiotic prescribing for respiratory tract infections in primary care across 13 countries. In over 2,600 patients, POC testing did not significantly reduce antibiotic use compared to usual care (45.7% vs 47.1%). Importantly, patient recovery was similar in both […]
Read more...
More news related to Healthy patients
